Brain scans may unlock migraine treatment success
NCT ID NCT06633484
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether brain scans can help predict which people with migraine will respond to a class of drugs called CGRP antibodies. Researchers used MRI to measure brain structure, activity, and blood flow in 219 adults with frequent migraine before and after 12 weeks of treatment. The goal is to find brain-based markers that separate responders from non-responders, which could lead to more personalized migraine care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
IRCCS Mondino Foundation
Pavia, Italy
-
University Medical Center Hamburg-Eppendorf
Hamburg, 20246, Germany
-
Vall d'Hebron Institute of Research
Barcelona, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Mind over migraine: brain network may explain why some expect side effects
- The eyes as a window to the brain: can a simple scan monitor MS, Alzheimer's, and Parkinson's?
- Experimental migraine drug JS010 takes first step in human safety trial
- Scientists probe shared pain pathways in endometriosis and migraine
- Brain scans and heat tests may predict migraine in teens
- Could a simple diary ease the burden of migraine?